NovAliX and Max Planck join forces to advance Cryo-EM driven drug discovery

Collaboration will make vital process of translating scientific research and academic insights into real therapies more efficient and more effective

07-Mar-2024 - NovAliX, a specialized Contract Research Organization dedicated to enabling drug discovery, announces its long-term strategic partnership with the Max Planck Institute (MPI) for Multidisciplinary Sciences in Göttingen. Through this collaboration, NovAliX and the MPI aim to make the vital process ...

Cloud-based platform for analyzing cryo-EM data secures pre-seed investment

Dutch biotech start-up aims to accelerate the development of new active ingredients

04-Mar-2024 - CryoCloud, a biotech start-up based in Utrecht in the Netherlands, recently closed a financing round of 500,000 euros. The company has thus reached an important milestone on its way to optimizing cryo-electron microscopy (cryo-EM). CryoCloud was founded in 2021 by Munich-based Robert Englmeier, ...

Merck Increases Global Commitment to Biosafety Testing With € 35 Million Investment in Scotland

Expansion creates nearly 500 new jobs in Glasgow and Stirling

02-Jun-2023 - Merck invests € 35 million in biosafety testing at its Glasgow and Stirling sites, Scotland. Biosafety testing is a critical step in the drug development and manufacturing process that ensures drugs are safe, efficacious, and meet regulatory requirements. The expansion will create nearly 500 new ...

New organ-on-chip pilot seeks to reduce animal testing in consumer health industry

Cooperation between Bayer, the start-ups esqLABS and Dynamic42, and Placenta Lab of Jena University Hospital

08-Mar-2023 - A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software. The pilot project, supported by esqLABS, Dynamic42, Placenta Lab of Jena ...

NanoTemper Technologies teams up with PharmAI to help researchers spot game-changing drug candidates from millions of possibilities

25-Mar-2021 - NanoTemper Technologies and PharmAI combine competencies to develop biophysical tools that remove costly and time-consuming guesswork from large datasets. PharmAI announced a partnership with NanoTemper Technologies, the most innovative producer of biophysical characterization devices. Together, ...

Bruker acquires Hamburg-based sensor start-up

27-Jun-2018 - Thanks to its innovative, patented sensor technologies, a portfolio company in the High-Tech Gründerfond (HTGF) has reached market maturity: USA’s Bruker Corporation has taken over Hamburg startup Sierra Sensors GmbH. Sierra Sensors develop and distribute biosensor-based analytical tools and ...

Eurofins acquisitions in Spain and Brazil

Villapharma and ASL Análises Ambientais acquired

02-Jan-2017 - Eurofins Scientific announces the signing of an agreement to acquire Villapharma Research SL (“Villapharma”) in Spain. The transaction is expected to close in February 2017, upon fulfilment of customary closing conditions. Villapharma provides organic synthesis and medicinal chemistry services to ...

MorphoSys Announces Acquisition of Sloning

Combination of Technologies Set to Increase Success Rates in Drug Development

11-Oct-2010 - MorphoSys AG announced the acquisition of Sloning BioTechnology GmbH. The transaction will make MorphoSys the sole source of Sloning's state-of-the-art Slonomics technology, which improves the assembly and quality of protein libraries. By integrating Slonomics into its existing antibody ...

Millipore Expands Drug Discovery and Development Services with BioAnaLab Acquisition

Acquisition extends Millipore’s biopharmaceutical services offering to European market

11-Aug-2009 - Millipore Corporation announced it has acquired BioAnaLab, a European-based services provider that specializes in the analysis of biologic drugs and vaccines. The transaction enables Millipore to expand its biopharmaceutical services business into Europe and further strengthens its position as a ...

Drug Development Technology: Frost & Sullivan Award goes to Imperacer

03-Nov-2008 - The 2008 European Immunoassay Frost & Sullivan Excellence in Technology Award has been awarded to Chimera Biotec. Chimera Biotec is recognized for its pioneering Imperacer® ultra-sensitive immunoassay system, which has a 1000-fold better sensitivity compared to ELISA (Enzyme-linked Immunosorbent ...